Thomas G. Frinzi has been serving as the President and Chief Executive Officer of STAAR SURGICAL since January 2020. With an extensive background in the medical device industry, Frinzi has been instrumental in steering the company towards significant growth and innovation. Prior to joining STAAR SURGICAL, he held the position of President and CEO at Vapotherm, a company focused on respiratory care. Under his leadership, Vapotherm successfully completed its initial public offering (IPO) in 2018, showcasing his ability to drive strategic initiatives and enhance shareholder value. Frinzi's career also includes a notable tenure at Insulet Corporation, where he served as President of the international business. During his time at Insulet, he played a key role in expanding the company's global footprint and increasing its market share in the diabetes care sector. His strategic vision and operational expertise have been pivotal in his various leadership roles, enabling him to effectively navigate the complexities of the healthcare industry. At STAAR SURGICAL, Frinzi is responsible for overseeing the company's overall operations and strategic direction. His leadership has been crucial in advancing the company's mission to develop and deliver innovative ophthalmic products, particularly in the area of implantable lenses for vision correction. Under his guidance, STAAR SURGICAL has continued to enhance its product offerings and strengthen its position in the global market, solidifying its reputation as a leader in the field of ophthalmology.